Physician profile
Robert J Anderson
NPI 1881685022
$3,836.59
in general payments reported to CMS, 2019-2025
12 companies · $192 in 2025
The $192 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,319 · 2020: $22.76 · 2021: $127 · 2022: $196 · 2023: $152 · 2024: $1,828 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,271 · Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,271.46 |
| Food and Beverage | $899.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,019.29 | 2024-2025 | Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan |
| W. L. Gore & Associates, INC. | $355.82 | 2020-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Abbott Laboratories | $284.91 | 2019 | |
| Chiesi USA, INC. | $242.69 | 2019 | |
| Janssen Pharmaceuticals, INC | $223.90 | 2019-2021 | |
| Stryker Corporation | $161.43 | 2019 | |
| Silk Road Medical, INC. | $151.52 | 2019 | |
| Endologix LLC | $128.98 | 2019 | |
| Smith+Nephew, INC. | $121.87 | 2019 | |
| La Jolla Pharmaceutical Company | $113.29 | 2019 | |
| Tactile Systems Technology INC | $18.07 | 2021 | |
| Organogenesis INC. | $14.82 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.